Medinice S.A.
ICE.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.59 | -0.40 | 0.12 | -0.00 |
| FCF Yield | -1.97% | -6.10% | -5.25% | -2.68% |
| EV / EBITDA | -112.34 | -40.21 | -47.88 | 1.05 |
| Quality | ||||
| ROIC | -1.13% | -1.90% | -1.34% | 48.35% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 5,652.63% |
| Cash Conversion Ratio | 0.77 | 1.22 | 1.14 | -0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -56.64% | -31.56% | -18.24% | -8.57% |
| Free Cash Flow Growth | 47.78% | -28.50% | -106.82% | 39.36% |
| Safety | ||||
| Net Debt / EBITDA | 0.14 | 1.56 | 5.81 | -0.21 |
| Interest Coverage | -92.20 | -142.00 | -124.00 | 2,915.86 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -5,001.92 | -6,177.60 | -5,274.55 | 2,163.78 |